These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 5051108)

  • 1. [Alphamercaptopropionylglycine in chronic hepatopathies].
    Cacciari G; Malaguti P; Zincati GC
    Policlinico Med; 1972; 79(3):165-73. PubMed ID: 5051108
    [No Abstract]   [Full Text] [Related]  

  • 2. [Nucleosides in the therapy of hepatopathies].
    Urbinati GC
    Clin Ter; 1966 Oct; 39(1):39-54. PubMed ID: 5998856
    [No Abstract]   [Full Text] [Related]  

  • 3. [Trofopar treatment of chronic diffuse diseases of the liver].
    Loginov AS; Nikolaeva AP; Bendikov EA; Blok IuE; Sukhareva GV
    Sov Med; 1989; (7):79-81. PubMed ID: 2799537
    [No Abstract]   [Full Text] [Related]  

  • 4. [Hepason in the treatment of hepatocellular diseases].
    Stazka Z; Korolko A
    Pol Tyg Lek; 1970 Jul; 25(28):1062-4. PubMed ID: 5451158
    [No Abstract]   [Full Text] [Related]  

  • 5. [Therapeutic efficiency of purified liver extract with an increased amount of vitamin B 12 in coenzymatic form in patients with liver diseases and rheumatoid arthritis].
    Guglielmi G; Garbagnati N; Iaschi P; Ciavarelli F; Ferrantelli D
    Clin Ter; 1969 Nov; 51(3):227-44. PubMed ID: 5407318
    [No Abstract]   [Full Text] [Related]  

  • 6. [Therapeutic effect of a preparation of total liver extract, cyanocobalamin and amino acids of the Krebs cycle, in acute and chronic liver diseases].
    Pignattari S; Sarti F; Toscano S; Dal Monte PR
    Minerva Med; 1972 Jul; 63(53):2861-72. PubMed ID: 5049878
    [No Abstract]   [Full Text] [Related]  

  • 7. [Considerations on the treatment with the combination of ribonucleosides, hepatic extract and vitamin B-12 (Nuclepatox) of acute and chronic liver diseases in the course of pulmonary tuberculosis].
    Ravazzoni C; Balzano E; Cuneo S
    Minerva Med; 1967 Jan; 58(6):141-7. PubMed ID: 6016918
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical trial of liver-protective agents containing cytidine and uridine in the therapy of patients with liver diseases].
    Grimaldi N; Santoro C
    Policlinico Med; 1971; 78(3):134-46. PubMed ID: 5568445
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical research on the hepatoprotective and antianemic action of hepatic opotherapy associated with nucleosides in high doses].
    Bestagno M
    Arch Maragliano Patol Clin; 1966; 22(3):299-309. PubMed ID: 5953073
    [No Abstract]   [Full Text] [Related]  

  • 10. [On the action of a total liver extract in subacute and chronic hepatopathies].
    Bazzicalupo G; Coscelli C
    Minerva Med; 1968 Sep; 59(76):3977-82. PubMed ID: 5698739
    [No Abstract]   [Full Text] [Related]  

  • 11. [Experimental clinical research on the therapeutic action of AM 65234].
    Forattini C; Pulliero G
    Clin Ter; 1966 Jul; 38(1):55-68. PubMed ID: 5990473
    [No Abstract]   [Full Text] [Related]  

  • 12. [Influence of treatment with nucleosides, liver extract and vitamin B 12 on various hepatic functional defects and on cellular proliferation of bone marrow in chronic liver diseases].
    Turpini R
    Clin Ter; 1970 Apr; 53(1):9-23. PubMed ID: 5472849
    [No Abstract]   [Full Text] [Related]  

  • 13. [The treatment of compensated hepatopathies using Sirepar and Ripason].
    Fassati P; Fassati M
    Cas Lek Cesk; 1967 Oct; 106(43):1143-50. PubMed ID: 6077099
    [No Abstract]   [Full Text] [Related]  

  • 14. [Therapeutic effectiveness of B-vitamins and other drugs in chronic liver-parenchyma diseases?].
    Wildhirt E
    Munch Med Wochenschr; 1968 Oct; 110(40):2313-4. PubMed ID: 5761605
    [No Abstract]   [Full Text] [Related]  

  • 15. [Therapeutic effectiveness of B-vitamins and other drugs in chronic liver-parenchyma diseases?].
    Heinrich HC
    Munch Med Wochenschr; 1968 Oct; 110(40):2311-2. PubMed ID: 5761604
    [No Abstract]   [Full Text] [Related]  

  • 16. [Treatment of alcoholic liver disease: studies of 10 cases].
    Silvi G; Stellato S
    Clin Ter; 1978 Feb; 84(3):275-82. PubMed ID: 639480
    [No Abstract]   [Full Text] [Related]  

  • 17. [Therapeutic activity in the geriatric age of hepatic opotherapy in association with high doses of nucleosides].
    Baldoni E; Floris E; Serenthà P; Negri U; Nuzzo L
    G Gerontol; 1968 Nov; 16(11):1261-99. PubMed ID: 5731973
    [No Abstract]   [Full Text] [Related]  

  • 18. [Hepa-listrocol in the therapy of chronic inflammatory liver diseases].
    Baum HH
    Landarzt; 1967 Apr; 43(11):530-3. PubMed ID: 5585071
    [No Abstract]   [Full Text] [Related]  

  • 19. [Controlled clinico-statistical studies on the role of the nucleosides in an association of hepatoprotective and anti-asthenic action].
    Soranzo ML
    Minerva Med; 1974 Feb; 65(8):391-7. PubMed ID: 4820721
    [No Abstract]   [Full Text] [Related]  

  • 20. [Report on the experiences in the ambutant treatment of hepatopathy with Heparhormforte].
    Ignatius A
    Landarzt; 1965 Sep; 41(25):1090-2. PubMed ID: 5857646
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.